MHLW Mulls “Ultra-Orphan” Drug System; Designation Might Become Possible with Pre-Clinical, Healthy Subject Data

The Ministry of Health, Labor and Welfare (MHLW) is set to begin discussions on bettering its current orphan drug designation system, including the creation of an “ultra-orphan drug” scheme to expedite designation for medicines that treat extremely rare diseases—based possibly...read more